Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 20/20 | 1.00 |
| ▸ | PTGDR | Q13258 | 10/20 | 1.00 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12000743 | 1.00 | PTGER4 (1.00) | PTGER4PTGDRPTGER2 | |
| SCHEMBL12000774 | 0.93 | PTGER4 (1.00) | PTGER4PTGDRPTGER2 | |
| SCHEMBL1748860 | 0.93 | PTGER4 (1.00) | PTGER4PTGDRPTGER2 | |
| SCHEMBL12900354 | 0.92 | PTGER4 (0.85) | PTGER4PTGDRPTGER2 | |
| SCHEMBL12900406 | 0.92 | PTGER4 (0.84) | PTGER4PTGDRPTGER2 | |
| SCHEMBL987966 | 0.92 | PTGER4 (0.84) | PTGER4PTGDRPTGER2 | |
| SCHEMBL12000770 | 0.91 | PTGER4 (0.83) | PTGER4PTGDRPTGER2 | |
| SCHEMBL1749275 | 0.91 | PTGER4 (0.83) | PTGER4PTGDRPTGER2 | |
| SCHEMBL12585693 | 0.89 | PTGER4 (0.80) | PTGER4PTGDR | |
| SCHEMBL30553043 | 0.89 | PTGER4 (0.85) | PTGER4PTGDRPTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2013169-B1 | INDOLE AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | MERCK CANADA INC (CA) | 2012-08-22 | — | — | EP | claimed |
| US-7968578-B2 | Indole amide derivatives as EP4 receptor antagonists | MERCK FROSST CANADA LTD. (CA) | 2011-06-28 | — | — | US | claimed |
| US-20090253756-A1 | Indole Amide Derivatives as EP4 Receptor Antagonists | MERCK CANADA INC. (CA) | 2009-10-08 | — | — | US | claimed |
| EP-2013169-B1 | INDOLE AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | MERCK CANADA INC (CA) | 2012-08-22 | — | — | EP | disclosed |
| US-7968578-B2 | Indole amide derivatives as EP4 receptor antagonists | MERCK FROSST CANADA LTD. (CA) | 2011-06-28 | — | — | US | disclosed |
| US-7968578-B2 | Indole amide derivatives as EP4 receptor antagonists | MERCK FROSST CANADA LTD. (CA) | 2011-06-28 | — | — | US | disclosed |
| US-20090253756-A1 | Indole Amide Derivatives as EP4 Receptor Antagonists | MERCK CANADA INC. (CA) | 2009-10-08 | — | — | US | disclosed |
| US-20090253756-A1 | Indole Amide Derivatives as EP4 Receptor Antagonists | MERCK CANADA INC. (CA) | 2009-10-08 | — | — | US | disclosed |
| WO-2007121578-A1 | INDOLE AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | MERCK FROSST CANADA LTD. (CA) | 2007-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253756-A1 | Indole Amide Derivatives as EP4 Receptor Antagonists | PTGER4, PTGER1, PTGER2 | PTGER4 1/4885PTGDR 8/4885PTGER2 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.